Clinical pharmacist-led medication reconciliation supplemented with medication review in admitted patients with chronic kidney disease: a cost-benefit analysis.

ABSTRACT:

Objective

Chronic kidney disease (CKD) is associated with a high economic burden, which is exacerbated by the high susceptibility to drug-related problems (DRPs) in this patient population. This study aimed to evaluate the cost-benefit ratio of medication reconciliation supplemented with medication review for inpatients with CKD, compared with the absence of this intervention.

Design

This was a cost-benefit analysis conducted along with a prospective interventional study.

Setting

The study was conducted at two hospitals in Jordan between February and May 2023.

Participants

The prospective interventional study included 142 admitted patients with CKD.

Interventions

Patients received medication reconciliation at admission and discharge as well as medication

SUBMITTER: Altawalbeh SM 

PROVIDER: S-EPMC11865755 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature